P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES

• Noa Wijnen,
• Farnaz Barneh,
• Thomas Meulendijks,
• Kim Klein,
• Ester Duddebach,
• Annelisa Cornel,
• Noël Dautzenberg,
• Minoo Ashtiani,
• Anja Krippner-Heidenreich,
• Stefan Nierkens,
• Olaf Heidenreich,
• Gertjan Kaspers

Affiliations

Noa Wijnen

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands

Farnaz Barneh

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands

Thomas Meulendijks

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands

Kim Klein

2 Wilhelmina Children’s Hospital/University Medical Center Utrecht, Pediatrics, Utrecht, The Netherlands

Ester Duddebach

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands

Annelisa Cornel

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands

Noël Dautzenberg

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands

Minoo Ashtiani

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands

Anja Krippner-Heidenreich

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands

Stefan Nierkens

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands

Olaf Heidenreich

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands

Gertjan Kaspers

1 Princess Maxima Center for Pediatric Oncology, Pediatric Hemato-Oncology, Utrecht, The Netherlands